Baxter International

DaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Care

Retrieved on: 
Thursday, November 30, 2023
Therapy, Baxter International, DaVita Inc., AmerisourceBergen, CSL Vifor, Conditional sentence, Friends, SoftServe, Wells Fargo, Volunteering, Purpose

DENVER, Nov. 30, 2023 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced the success of its 2023 Move It With Purpose (MIWP) event. MIWP is an annual community-driven initiative that brings together DaVita teammates, friends, family members, and the kidney care community to support Bridge of Life, a nonprofit founded by DaVita to support the prevention and treatment of chronic disease.

Key Points: 
  • DENVER, Nov. 30, 2023 /PRNewswire/ -- DaVita , a leading provider of kidney care services, today announced the success of its 2023 Move It With Purpose (MIWP) event.
  • MIWP is an annual community-driven initiative that brings together DaVita teammates, friends, family members, and the kidney care community to support Bridge of Life, a nonprofit founded by DaVita to support the prevention and treatment of chronic disease.
  • The month-long event challenges participants to "Move It" by engaging in a physical activity of their choice.
  • This year's fundraiser achieved record-breaking participation, with more than 6,400 movers logging nearly 400,000 total miles.

Wireless Healthcare Market in APAC to grow by USD 41.13 billion from 2022 to 2027 | Growth Driven by Increasing adoption of wearables- Technavio

Retrieved on: 
Monday, November 27, 2023
Key (company), WSN, EHR, Handsfree, Electronics, Stryker Corporation, Baxter International, Masimo, Privacy, Hospital, Insurance, Patient, EMR, ISO, Oracle Corporation, USD, Medtronic, Canon Inc., Analysis, Software, Communication, Fujifilm Corp. v. Benun, ISO 9001:2015, Physician, Certification, Telehealth, Retail, Health care, Application, Bionics

The potential growth difference for the wireless healthcare market in APAC from 2022 to 2027 is USD 41.13 billion.

Key Points: 
  • The potential growth difference for the wireless healthcare market in APAC from 2022 to 2027 is USD 41.13 billion.
  • The increasing adoption of wearables is the key factor driving the market growth.
  • The wireless sensor networks (WSN) market size is estimated to grow at a CAGR of 17.32% between 2022 and 2027.
  • The Biometric Access Control Systems Market size is estimated to grow at a CAGR of 7.77% between 2022 and 2028.

The Pre-filled Syringes Market size to grow by USD 3.51 billion from 2022 to 2027| North America is estimated to contribute 36% to the growth of the global market - Technavio

Retrieved on: 
Tuesday, November 14, 2023
Syringe, Glass, Conditional sentence, Limited partnership, Incidence, Baxter International, ROW, Fresenius (company), Risk, Blow fill seal, USD, Glycopyrronium bromide, Geography, CDC, Oxygen, Growth, Morphine, Diabetes, Marketing, COVID-19

By geography, the market is segmented by North America, Europe, Asia, and the Rest of the World (ROW).

Key Points: 
  • By geography, the market is segmented by North America, Europe, Asia, and the Rest of the World (ROW).
  • North America is estimated to contribute 36% to the growth of the global market during the forecast period.
  • The pre-filled syringes market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market.
  • The market share growth by the glass pre-filled syringes segment will be significant during the forecast period.

MeMed Further Solidifies Board of Directors Appointing Scott Garrett

Retrieved on: 
Thursday, November 9, 2023
Water, MA, AdvaMed, Dade Behring, Health, Senior, Internet meme, Growth, Baxter International, Water Street, Minerva Surgical, Inc. v. Hologic, Inc., Beckman Coulter, Management

HAIFA, Israel; BOSTON, MA – 9 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Scott Garrett to its Board of Directors.

Key Points: 
  • HAIFA, Israel; BOSTON, MA – 9 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Scott Garrett to its Board of Directors.
  • Scott Garrett is currently a Senior Operating Partner at Water Street Healthcare Partners, a private equity firm focused solely on healthcare investments.
  • I'm truly enthusiastic about my appointment to MeMed's Board of Directors and eagerly anticipate helping the MeMed team achieve its operational and strategic goals.”
    Dr. Eran Eden, CEO of MeMed, noted, “We’re excited to welcome Scott Garrett to our Board and leadership team.
  • I look forward to working with Scott to further our mission and establish MeMed as a leader in the emerging field of advanced host-response.”

Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure

Retrieved on: 
Monday, November 6, 2023
Health, Hospitals, Surgery, Health Technology, Practice Management, General Health, Water, RPM, MB, PD, NYSE, Health care, HDF, APD, HD, In re Caremark International Inc. Derivative Litigation, Infection, Peritoneal dialysis, Electricity, Kidney, Research, Inflammation, Hemofiltration, Dialysis, ASN, Risk, HDX, Blood, Hospital, Patient, Bed, Baxter International, Failure, Cardiovascular disease, Medical device, Pharmaceutical industry

Technique failure can be due to several factors and results in PD patients being switched to in-center dialysis.

Key Points: 
  • Technique failure can be due to several factors and results in PD patients being switched to in-center dialysis.
  • In propensity matched patients, the use of Sharesource was associated with a 77% reduction in risk of technique failure (HR 0.23 95% CI 0.06-0.83, p = 0.024).
  • Water consumption per year with online HDF was 4.1 million liters, but consumption was 27% lower with the use of HDx therapy.
  • Furthermore, data indicate HDx therapy demonstrated 17% lower electricity and associated costs.

US Anesthesia Drugs and Devices Market Set to Reach $6.83 Billion in 2023, Driven by Growing Healthcare Expenditure - ResearchAndMarkets.com

Retrieved on: 
Monday, November 6, 2023
Pharmaceutical, Health, Medical Devices, Patient, Headache, Ageing, Anesthesiology, Pain, KKR, Vomiting, Abdominal ultrasonography, Somnolence, Prevalence, AstraZeneca, Conditional sentence, Lidocaine, Anesthetic, Shivering, MAC, Envision Healthcare, Nausea, 3M, Abbott Laboratories, General Electric Company, SunMed BRT station, Growth, Fungal infection, TeamHealth, COVID-19, Inhalation, Risk, AbbVie, Device, Benzocaine, Consciousness, Becton, Dickinson and Company headquarters, Blackstone, Braun, Baxter International, Ventilation, Central nervous system, ICU Medical, ICU, Pharmaceutical industry, Dentistry, Bupivacaine, Prilocaine, Anesthesia, Ropivacaine

The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.

Key Points: 
  • The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.
  • Among these segments, anesthesia drugs currently hold the majority share, while the anesthesia devices segment is expected to experience substantial growth due to increased healthcare expenditure in the region.
  • In terms of types, the US anesthesia drugs market is categorized into General, Local, and other anesthesia.
  • The development of novel anesthesia drugs through pharmaceutical R&D is expected to create growth opportunities in the "other anesthesia drugs" segment.

ProfoundBio Readies for Next Phase of Growth with Management Team Additions and Advisory Board Appointment

Retrieved on: 
Thursday, November 2, 2023
Research, Thought Leadership, Clinical Trials, Professional Services, Biotechnology, Health, Pharmaceutical, Science, Oncology, IPO, Pharmacyclics, Catalent, Alder, Therapy, Hematology, Nutcracker, MBS, Head, CMC, Seagen, Lundbeck, University of California, Acquisition, PTK7, Protein, Economics, Lundbeck Seattle Biopharmaceuticals, Yale University, Immunotherapy, Growth, SITC, ADC, Division, University, Biology, Amgen, Baxter International, Internal medicine, Merrill (company), Business, Keck Graduate Institute, Society for Immunotherapy of Cancer, Genentech, Society, Cancer, Seattle, University of Southern California, Coronavirus Scientific Advisory Board, Fine chemical, Management, Biochemistry, Proteolix, Chiron, Spacecraft, Western Washington University

We are thrilled to welcome Erin and Kevin to our leadership team as we plan for this next stage of growth.

Key Points: 
  • We are thrilled to welcome Erin and Kevin to our leadership team as we plan for this next stage of growth.
  • In addition, as chair of our Scientific Advisory Board, Lori brings decades of clinical thought-leadership and strategic product development experience in ADCs.
  • We look forward to working alongside them.”
    ProfoundBio also announced additional changes to the company's executive team.
  • Co-founders Tae Han and Xiao Shang will take on the roles of chief strategy officer and head of CMC, respectively.

Anumana Appoints Maulik Nanavaty as CEO

Retrieved on: 
Thursday, October 19, 2023
Cardiology, Software, Health, Artificial Intelligence, Medical Devices, Data Management, Hospitals, Technology, FDA, ECG, R. Aravamudan, Interventional cardiology, Heart, Automated ECG interpretation, Multimedia, Mayo Clinic, Growth, Pharmacy, Partnership, DSM-IV codes, Baxter International, Reema Nanavaty, University, Algorithm, Therapy, Champaign–Urbana metropolitan area, Management, Medical device, Boston Scientific

Anumana, Inc ., a leading AI-driven health technology company and portfolio company of nference , today announced that Maulik Nanavaty has joined Anumana as chief executive officer and member of the Board of Directors.

Key Points: 
  • Anumana, Inc ., a leading AI-driven health technology company and portfolio company of nference , today announced that Maulik Nanavaty has joined Anumana as chief executive officer and member of the Board of Directors.
  • Murali Aravamudan, co-founder of Anumana and nference, has transitioned to executive chairman of the Anumana Board of Directors while continuing as CEO of nference.
  • Nanavaty will lead Anumana through a period of growth as the company begins deploying and commercializing its multi-indication ECG-AI platform technology.
  • View the full release here: https://www.businesswire.com/news/home/20231019420956/en/
    Maulik Nanavaty has joined Anumana as chief executive officer and member of the Board of Directors.

Oneview Healthcare and Baxter Announce Connected Care Collaboration During Meeting with Enterprise Ireland

Retrieved on: 
Tuesday, October 17, 2023
Hardware, Telemedicine, Virtual Medicine, Data Management, Consumer Electronics, Technology, Other Policy Issues, Audio, Video, Practice Management, Apps, Applications, General Health, Hospitals, Public Policy, Government, Software, Nursing, Health, Baxter International, Partnership, Nursing care plan, Multimedia, Hospital, Midwestern United States, Health care, AUC, Employment, Caregiver, Baxter, Education, Enterprise, CXP, Growth, Oneview, Patient, Enterprise Ireland

Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased to announce the official launch of their strategic relationship in the United States.

Key Points: 
  • Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased to announce the official launch of their strategic relationship in the United States.
  • View the full release here: https://www.businesswire.com/news/home/20231017296352/en/
    Oneview Healthcare, Enterprise Ireland, and Baxter at the Baxter Headquarters.
  • Baxter will now offer Oneview’s Care Experience Platform (CXP) to their hospital customers across the United States.
  • During the meeting with the Irish government Minister for Enterprise, Trade, and Employment, Simon Coveney, representatives from both Oneview Healthcare and Baxter expressed their enthusiasm for the collaboration and outlined their shared vision for the future of healthcare.

Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope

Retrieved on: 
Monday, October 16, 2023
Medical Devices, Health, Health Technology, General Health, Optical, Biotechnology, Diagnosis, Baxter International, NYSE, Eye, American Academy, Otoscope, Information International, Inc., LED, Conference, Patient, Ophthalmoscopy, Nursing

Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope.
  • “The iExaminer Pro System uses the latest tech, allowing providers to spend more time focusing on the thing that matters most – their patients.”
    The PanOptic Plus Ophthalmoscope with iExaminer Pro System adds the ability to connect a smart device to capture images for further examination and enables clinicians to move quickly from an optical exam to adding digital image capture.
  • The addition of digital image capture capability for eye exams represents the company’s continued commitment to using connected devices to help improve patient outcomes via routine physical exams.
  • The PanOptic Plus and MacroView Plus tools offer clinicians bigger views compared to standard ophthalmoscopes and otoscopes, plus additional key features such as long-lasting LED lamps and DuraShock technology for durability.